Año: 2024
Journal Impact Factor (JIF): 4.60
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | SCIE | 17/137 | Q1 | T1 | D2 |
| PHARMACOLOGY & PHARMACY | SCIE | 57/352 | Q1 | T1 | D2 |
Año: 2024
Journal Citation Indicator (JCI): 1,140
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | 22/137 | Q1 | T1 | D2 | 84,31 |
| PHARMACOLOGY & PHARMACY | 65/353 | Q1 | T1 | D2 | 81,73 |
Año:
2024
CiteScore:
8,700
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 3/77 | Q1 | T1 | D1 |
| Biochemistry | 70/441 | Q1 | T1 | D2 |
| Infectious Diseases | 45/357 | Q1 | T1 | D2 |
| Microbiology (medical) | 26/148 | Q1 | T1 | D2 |
| Pharmacology (medical) | 31/275 | Q1 | T1 | D2 |
| Microbiology | 38/188 | Q1 | T1 | D3 |
SJR año:
2024
Factor de Impacto:
1,114
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 10/129 | Q1 | T1 | D1 |
| Infectious Diseases | 68/361 | Q1 | T1 | D2 |
| Microbiology (medical) | 30/150 | Q1 | T1 | D2 |
| Pharmacology (medical) | 51/286 | Q1 | T1 | D2 |
| Biochemistry | 105/447 | Q1 | T1 | D3 |
| Microbiology | 47/185 | Q2 | T1 | D3 |
| Agencia | Código de Proyecto |
|---|---|
| Andalusia Government | - |
| European Union | - |
| Instituto de Salud Carlos III (ISCIII) | PI22/01464; PI23/01760 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Mairal, CC | Virgen del Rocio University Hospital (Spain) |
| 2 | Universidad Loyola Andalucia; Virgen del Rocio University Hospital; Ctr Invest Biomed Red Enfermedades Infecciosas CIB (Spain) | |
| 3 | Rodríguez-Villodres, A | Virgen del Rocio University Hospital; Ctr Invest Biomed Red Enfermedades Infecciosas CIB (Spain) |
| 4 | Cisneros, JM | Universidad de Sevilla; Virgen del Rocio University Hospital; Ctr Invest Biomed Red Enfermedades Infecciosas CIB (Spain) |
| 5 | Lepe, JA | Virgen del Rocio University Hospital; Ctr Invest Biomed Red Enfermedades Infecciosas CIB; University of Seville Faculty of Medicine (Spain) |
| 6 | Virgen del Rocio University Hospital; Ctr Invest Biomed Red Enfermedades Infecciosas CIB (Spain) |